SSLS.S. Lazio S.p.A.

Man Utd stock has performed worse than all major European teams, research from Finder shows.

If you are weighing your next move with Banca IFIS, you are not alone. After all, the stock has served up a mix of intrigue and promise this year, catching plenty of attention across the financial landscape. In the past week, the share price edged down just 0.8%, but zoom out a bit and the bigger story comes into focus. The stock is up 4.1% over the past month, 9.2% year to date, and a striking 20.5% over the past twelve months. Stretch that time frame further, and Banca IFIS has rewarded...

The cider brand has added a high-contrast NaviLens QR code to its cans.

BioReference health, JPMorgan Chase and an Italian fashion retailer are making the job cuts amid market uncertainty

Novartis will acquire Tourmaline Bio for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion on a fully diluted basis, the Swiss pharma giant said on Tuesday. Tourmaline is focused on developing pacibekitug, a promising targeted therapy with the potential to reduce systemic inflammation, as a treatment option for atherosclerotic cardiovascular disease, Novartis said in a statement. With the deal, Novartis will acquire a Phase III-ready asset that will complement its existing cardiovascular disease portfolio, it said.